期刊文献+

四种剂型活性炭在口服毒物治疗中的临床观察 被引量:3

Clinical study of four forms of activated charcoal in treatment of oral poisoning
原文传递
导出
摘要 目的评价四种不同剂型活性炭在经口中毒治疗中的适用性。方法选取35名护士应用四种不同剂型活性炭进行模拟洗胃,分别填写可操作性调查表,记录洗胃时间、使用液体量、洗胃管堵塞次数并评出最优和最差剂型。选取50例健康志愿者分别口服四种不同剂型活性炭,填写适口性调查表,适口性分为很好、一般、可接受、难以接受。对数据进行统计学处理,评价四种剂型活性炭的临床适用性。结果护士可操作性调查组:不同剂型洗胃时间分别为:粉剂(151.8±17.8)s、混悬液(96.9±24.8)s、胶囊(319±82.4)s、片剂(314.3±93.3)s,四种剂型之间差异有统计学意义(P〈0.001)。胃管堵塞次数:粉剂和混悬液无堵塞,胶囊(4.00±5.00)次、片剂(5.55±3.00)次,四种剂型之间差异有统计学意义(P〈0.001)。志愿者适口性组:四种剂型活性炭适口性比较差异有统计学意义(P〈0.001)。在两组结果,每两种剂型比较,除胶囊和片剂之间无差异外(P〉0.05),余三种剂型相互比较差异均有统计学意义。结论不同剂型活性炭临床适用性存在明显差别,护士可操作性混悬液最佳,粉剂、胶囊和片剂较差。胶囊和片剂适口性好,适于清醒依从性好的患者。混悬液和粉剂适口性不好。但更适合昏迷患者的临床抢救。 Objective To evaluate the applicability of activated charcoal in treatment of oral poisoning. Methods The feasibility of clinical manipulation and tastiness of 4 forms of activated charcoal were investigated, with different dosage forms in 35 nurses and 50 volunteers, respectively. The feasibility of the clinical manipulation was assessed by gastrolavage time and block numbers of stomach duct, and the tastiness by volunteers' taking orally. Results The gastrolavage time( 151.8 ± 17.8 ) s for powder, (96.9± 24.80) s for suspension, (319.0 ± 82.4 ) s for tablet and ( 314.3 ± 93.3 ) s for suspension ( P 〈 0.001 ). Conclusion There are significant differences in the applicability of activated charcoal in different dosage forms. The suspension is the best form in feasibility. Capsule and tablet are better than powder and suspension in tastiness. Suspension and powder are the worst to accept.
出处 《中国综合临床》 北大核心 2008年第8期742-744,共3页 Clinical Medicine of China
基金 基金项目:国家科技部社会公益项目(2004DIB1J037)
关键词 经口中毒 活性炭 洗胃 Oral poisoning Activated charcoal Gastrolavage
  • 相关文献

参考文献6

  • 1Chyka PA, Seger D. Position statement : single-dose activated charcoal. AACT EAPCCT[ J]. Clin Toxical, 1997,35 (7) :721-741.
  • 2黄韶清.急性中毒的救治与进展[J].中华急诊医学杂志,2004,13(7):439-440. 被引量:6
  • 3Levy G. Gastrointestinal clearence of drugs with activated charcoal [J]. New Engl J Med ,1982,307( 11 ) :676-678.
  • 4Lalonde RL, Deshpande R, Hamilton PP, et al. Acceleration of digoxin clearance by activated charcoal [ J]. Clin Pharmacol Ther, 1985,37 (4) :367-371.
  • 5Guay DRP, Meatherall RC, Macaulay PA, et al. Activated charcoal absorption of diphenhydramine[ J]. Int J Clin Pharmacol Ther Toxicol,1984,22(6) :395-400.
  • 6Neuvonen PJ, Kannisto H, Lankinen S. Capacity of two forms of activated charcoal to adsorb nefopam in vitio and to reduce its toxicity in vivo[J]. J Toxicol Clin Toxicol, 1984,21 (4) :333-342.

二级参考文献5

共引文献5

同被引文献32

  • 1黄韶清.急性中毒的救治与进展[J].中华急诊医学杂志,2004,13(7):439-440. 被引量:6
  • 2王飞,孙海燕,姚波,闫卫军,沙海旺,李莉.活性炭胃肠灌洗在有机磷农药口服中毒中的临床应用[J].延安大学学报(医学科学版),2004,2(4):33-33. 被引量:2
  • 3彭丽珍.急性毒鼠强中毒的急救与护理[J].黑龙江医学,2005,29(4):295-296. 被引量:1
  • 4张李(综述),梁寒(审校).纳米活性炭的特性及其在胃癌治疗中的应用[J].国际肿瘤学杂志,2007,34(1):52-55. 被引量:17
  • 5Heffner JE,Klein JS.Recent advances in the diagnosis and management of malignant pleural effusions[J].Mayo Clin Proc,2008,83 (2):235-250.
  • 6Tassi GF,Cardillo G,Marehetti GP,et al.Diagnostic and therapeutical management of malignant pleural effusion[J].Ann Oncol,2006,17(Suppl 2):ii11-12.
  • 7Lee YC,Baumann MH,Maskell NA,et al.Pleurodesis practico for malignant pleural effusions in five English-speaking countries:survey of puimonologists[J].Chest,2003,124 (6):2229-2238.
  • 8Tan C,Sedrakyan A,Browne J,et al.The evidence on the effectiveness of management for malignant pleural effusion:a systematic review[J].Eur J Cardiothorac Surg,2006,29(5):829-838.
  • 9Haas AR,Sternum DH,Musani AI.Malignant pleural effusions:management options with consideration of coding,billing,and a decision approach[J].Chest,2007,132 (3):1036-1041.
  • 10Antunes G,Neville E.Management of malignant pleural effusions[J].Thorax,2000,55 (12):981-983.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部